<code id='4F980EE1B2'></code><style id='4F980EE1B2'></style>
    • <acronym id='4F980EE1B2'></acronym>
      <center id='4F980EE1B2'><center id='4F980EE1B2'><tfoot id='4F980EE1B2'></tfoot></center><abbr id='4F980EE1B2'><dir id='4F980EE1B2'><tfoot id='4F980EE1B2'></tfoot><noframes id='4F980EE1B2'>

    • <optgroup id='4F980EE1B2'><strike id='4F980EE1B2'><sup id='4F980EE1B2'></sup></strike><code id='4F980EE1B2'></code></optgroup>
        1. <b id='4F980EE1B2'><label id='4F980EE1B2'><select id='4F980EE1B2'><dt id='4F980EE1B2'><span id='4F980EE1B2'></span></dt></select></label></b><u id='4F980EE1B2'></u>
          <i id='4F980EE1B2'><strike id='4F980EE1B2'><tt id='4F980EE1B2'><pre id='4F980EE1B2'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:8
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          Surge in Apellis stock fueled by confidence in safety of its eye drug
          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto

          read more
          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more

          Biogen walks away from Aduhelm, years after polarizing approval

          JessicaRinaldi/TheBostonGlobeBiogenisgivingupitsownershipofAduhelm,theAlzheimer’sdiseasetreatmentwho